18F-FDG PET-CT in soft tissue sarcomas: staging, restaging, and prognostic value?

被引：14
作者：
Gabriel, Michael [1 ,2 ]
Rubello, Domenico [3 ]
机构：
[1] Johannes Kepler Univ Linz, Fac Med, Allgemeines Krankenhaus Stadt Linz, Dept Nucl Med & Endocrinol, A-4021 Linz, Austria
[2] Med Univ Innsbruck, Univ Clin Nucl Med, A-6020 Innsbruck, Austria
[3] Santa Maria della Misericordia Hosp, Nucl Med & PET CT Ctr Dept, Rovigo, Italy
来源：
NUCLEAR MEDICINE COMMUNICATIONS | 2016年 / 37卷 / 01期
关键词：
F-18-FDG; PET-CT; prognostic value; restaging; soft tissue sarcoma; staging; POSITRON-EMISSION-TOMOGRAPHY; FDG-PET; SUNITINIB MALATE; PHASE-II; NEOADJUVANT CHEMOTHERAPY; PART SARCOMA; DOUBLE-BLIND; TUMOR GRADE; BONE; THERAPY;
D O I：
10.1097/MNM.0000000000000407
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
The aim of this article was to review the current role of PET/computed tomography (CT) in soft tissue sarcomas with respect to staging, restaging, and prognostic value. Fluorine-18-fluorodeoxyglucose PET, for instance, can be very useful in differentiating recurrent disease from scar tissue during follow-up. Other indications of PET-CT are still evolving, especially in the light of new molecular drugs. Different aspects of PET/CT imaging in soft tissue sarcomas are overviewed including organ-specific merits, limitations, and potential pitfalls. Finally, methodological considerations on PET/MRI are also briefly discussed.
引用
收藏
页码：3 / 8
页数：6
相关论文
共 58 条
[1]  
Agulnik M., 2009, J. Clin. Oncol., V27, P10522
[2]   18F-Fluorodeoxyglucose positron emission tomography/computed tomography for the detection of recurrent bone and soft tissue sarcoma [J].
Al-Ibraheem, Akram ;
Buck, Andreas K. ;
Benz, Matthias R. ;
Rudert, Maximilian ;
Beer, Ambros J. ;
Mansour, Asem ;
Pomykala, Kelsey L. ;
Haller, Bernhard ;
Juenger, Hendrik ;
Scheidhauer, Klemens ;
Schwaiger, Markus ;
Herrmann, Ken .
CANCER, 2013, 119 (06) :1227-1234
[3]  
[Anonymous], CANC FACTS FIG 2015
[4]  
[Anonymous], ASCO M ABSTR S
[5]   FDG-PET/CT Imaging Predicts Histopathologic Treatment Responses after the Initial Cycle of Neoadjuvant Chemotherapy in High-Grade Soft-Tissue Sarcomas [J].
Benz, Matthias R. ;
Czernin, Johannes ;
Allen-Auerbach, Martin S. ;
Tap, William D. ;
Dry, Sarah M. ;
Elashoff, David ;
Chow, Kira ;
Evilevitch, Vladimir ;
Eckardt, Jeff J. ;
Phelps, Michael E. ;
Weber, Wolfgang A. ;
Eilber, Fritz C. .
CLINICAL CANCER RESEARCH, 2009, 15 (08) :2856-2863
[6]   FDG PET imaging for grading and prediction of outcome in chondrosarcoma patients [J].
Brenner, W ;
Conrad, EU ;
Eary, JF .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2004, 31 (02) :189-195
[7]   Imaging and diagnostic strategy of soft tissue tumors in children [J].
Brisse, H ;
Orbach, D ;
Klijanienko, J ;
Fréneaux, P ;
Neuenschwander, S .
EUROPEAN RADIOLOGY, 2006, 16 (05) :1147-1164
[8]  
Brown RS, 1999, J NUCL MED, V40, P556
[9]   The Epidemiology of Sarcoma [J].
Burningham, Zachary ;
Hashibe, Mia ;
Spector, Logan ;
Schiffman, Joshua D. .
CLINICAL SARCOMA RESEARCH, 2012, 2
[10]  
Cancer Research UK, Soft tissue sarcoma statistics
123456